NuCana (NCNA) Cash from Investing Activities (2017 - 2025)

NuCana's (NCNA) quarterly Cash from Investing Activities came in at $178242.3 in Q4 2025, up 531.24% year-on-year from $28237.0 in Q4 2024, and up 106.4% quarter-over-quarter from $86359.2 in Q3 2025.

NuCana (NCNA) Cash from Investing Activities (2017 - 2025) Analysis & Trends

NuCana has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $178242.3 for Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at $178242.3, up 531.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $316225.9 (up 212.72% YoY), and the FY2025 annual result was $209643.1, up 107.6% from the prior year.
  • Cash from Investing Activities came in at $178242.3 for Q4 2025 at NuCana, up from $86359.2 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.4 million in Q3 2023 to a low of -$3.9 million in Q3 2021.
  • The 5-year median for Cash from Investing Activities is $28509.2 (2024), against an average of -$42517.4.
  • Across the five-year window, Cash from Investing Activities tumbled 406.97% in 2021 and soared 3249.53% in 2023, its largest moves.
  • NuCana's Cash from Investing Activities stood at -$624128.9 in 2021, then soared by 130.07% to $187668.5 in 2022, then plunged by 64.95% to $65781.0 in 2023, then sank by 57.07% to $28237.0 in 2024, then soared by 531.24% to $178242.3 in 2025.
  • The last three Cash from Investing Activities figures came in at $178242.3 (Q4 2025), $86359.2 (Q3 2025), and $28237.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.89 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -431.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 579,519.10
10 NuCana 29.13 Bn 29.13 Bn - 178,242.27

Historic Data

Download Data
DateValue
Dec 31, 2025 178,242.27
Dec 31, 2025 178,242.27
Sep 30, 2025 86,359.18
Sep 30, 2025 86,359.18
Dec 31, 2024 28,237.04
Dec 31, 2024 28,237.04
Sep 30, 2024 23,387.40
Sep 30, 2024 23,387.40
Jun 30, 2024 -5,048.88
Jun 30, 2024 -5,048.88
Mar 31, 2024 54,546.28
Mar 31, 2024 54,546.28
Dec 31, 2023 65,781.05
Dec 31, 2023 65,781.05
Sep 30, 2023 3.36 Mn
Sep 30, 2023 3.36 Mn
Jun 30, 2023 28,781.35
Jun 30, 2023 28,781.35
Mar 31, 2023 198,128.05
Mar 31, 2023 198,128.05